Search

Author/Creator Crooke, Rosanne M

1. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. Issue 10057 (5th November 2016)

Authors:
Viney, Nicholas J; van Capelleveen, Julian C; Geary, Richard S; Xia, Shuting; Tami, Joseph A; Yu, Rosie Z; Marcovina, Santica M; Hughes, Steven G; Graham, Mark J; Crooke, Rosanne M; Crooke, Stanley T; Witztum, Joseph L; Stroes, Erik S; Tsimikas, Sotirios
Journal:
Lancet
Issue:
Volume 388:Issue 10057(2016)
Page Start:
2239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. Issue 10002 (10th October 2015)

Authors:
Tsimikas, Sotirios; Viney, Nicholas J; Hughes, Steven G; Singleton, Walter; Graham, Mark J; Baker, Brenda F; Burkey, Jennifer L; Yang, Qingqing; Marcovina, Santica M; Geary, Richard S; Crooke, Rosanne M; Witztum, Joseph L
Journal:
Lancet
Issue:
Volume 386:Issue 10002(2015)
Page Start:
1472
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗